TransMedics Group is trading at $83.00 (+4.02%); available coverage has not established a specific cause for the intraday gain.
- The company’s latest listed release was its September 28 CFO appointment, which reaffirmed its outlook.
- The S&P 500 and Nasdaq were modestly higher, but neither exceeded the stated 0.5% threshold for attributing the move to broad-market momentum.